UBS Upgrades Rentokil Initial to Neutral
Portfolio Pulse from Benzinga Newsdesk
UBS has upgraded Rentokil Initial (NYSE:RTO) from a Sell to a Neutral rating.
July 01, 2024 | 12:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS has upgraded Rentokil Initial from a Sell to a Neutral rating, indicating a more positive outlook on the stock.
The upgrade from UBS suggests a more favorable view of Rentokil Initial's prospects, which could lead to increased investor confidence and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100